Valuation: Abbott Laboratories

Market Cap 16TCr 14TCr 13TCr 12TCr 23TCr 15,35600Cr 23TCr 1,55300Cr 61TCr 7,54100Cr 60TCr 59TCr 26,04300Cr P/E 2026 *
22.8x
P/E 2027 * 19.4x
Enterprise Value 17TCr 15TCr 14TCr 13TCr 24TCr 16,47500Cr 25TCr 1,66700Cr 65TCr 8,09000Cr 65TCr 63TCr 27,94000Cr EV / Sales 2026 *
3.43x
EV / Sales 2027 * 3.09x
Free-Float
86.73%
Yield 2026 *
2.76%
Yield 2027 * 2.95%
1 day-0.68%
1 week-2.53%
Current month+1.90%
1 month+8.00%
3 months-4.70%
6 months-22.38%
Current year-22.67%
1 week 81.58
Extreme 81.58
84.72
1 month 75.16
Extreme 75.16
85.36
Current year 69.76
Extreme 69.76
109.34
1 year 69.76
Extreme 69.76
116.8
3 years 69.76
Extreme 69.76
133.78
5 years 69.76
Extreme 69.76
133.78
10 years 34.46
Extreme 34.461
133.78
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-2.53% - - 16TCr
-0.36%+0.61%-7.06%-5.09% 11TCr
+0.89%+2.54%+3.70%+60.04% 5.9TCr
+0.78%+0.39%+41.69%+56.60% 5.17TCr
+1.24%-1.10%-12.58%-40.82% 4.19TCr
-1.12%-5.08% - - 3.47TCr
+1.85%+5.48%-8.42%-43.01% 2.89TCr
+1.69%+0.58%+58.33%-6.25% 2.5TCr
+0.49%+1.77%-4.82%-5.11% 2.11TCr
+3.27%+5.52%-7.07%-17.12% 2.04TCr
Average +0.83%+0.74%+7.97%-0.09% 4.33TCr
Weighted average by Cap. +0.26%+0.58%+5.79%+6.64%

Financials

2026 *2027 *
Net sales 5.03TCr 4.41TCr 4.08TCr 3.76TCr 7.1TCr 4,81000Cr 7.24TCr 49TCr 19TCr 2,36200Cr 19TCr 18TCr 8,15700Cr 5.47TCr 4.8TCr 4.45TCr 4.09TCr 7.74TCr 5,24000Cr 7.89TCr 53TCr 21TCr 2,57300Cr 21TCr 20TCr 8,88600Cr
Net income 701.79Cr 615.54Cr 570.11Cr 524.56Cr 992.19Cr 67TCr 1.01TCr 6.79TCr 2.66TCr 33TCr 2.64TCr 2.58TCr 1,13900Cr 838.93Cr 735.83Cr 681.52Cr 627.07Cr 1.19TCr 80TCr 1.21TCr 8.12TCr 3.19TCr 39TCr 3.15TCr 3.08TCr 1,36200Cr
Net Debt 1.17TCr 1.03TCr 949.56Cr 873.7Cr 1.65TCr 1,11900Cr 1.68TCr 11TCr 4.44TCr 55TCr 4.39TCr 4.29TCr 1,89700Cr 885.69Cr 776.84Cr 719.5Cr 662.02Cr 1.25TCr 85TCr 1.28TCr 8.58TCr 3.36TCr 42TCr 3.33TCr 3.25TCr 1,43800Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
13/26/13 €81.58 -0.68% 23
10/26/10 €82.14 0.00% 10
09/26/09 €82.14 -3.05% 260
08/26/08 €84.72 -0.75% 30
07/26/07 €85.36 +1.98% 50
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
92.11USD
Average target price
116.40USD
Spread / Average Target
+26.37%

Quarterly revenue - Rate of surprise